The authors especially Observe The shortage of randomized managed trials for orthopaedic indications—that means we could’t confidently say it really works, what the true aspect-influence profile is, or what a “safe dose” could well be in the actual environment (systematic review, 2024).When the purpose is “less downtime, a lot more teachi